Navigation Links
2-D MARKER from Pierce Biotechnology, Inc.

Products2-D MARKER from Pierce Biotechnology, Inc.
Company Pierce Biotechnology, Inc.
Item 2-D MARKER
Price 
Description The new Pierce ready-to-use 2-D gel marker mix was designed specifically to aid the proteome analyst. This 2-D gel marker mix contains a complement of seven reduced and denatured proteins that offer important features of value to those who use markers to assess 2-D system performance or estimate pI and molecular weight values of proteins undergoing 2-D separation and analysis.

A unique complement of proteins

Each protein in this marker mix was carefully selected to give a useful range of molecular weight and pI coverage. Proteins were selected that give a variety of features from tight single spots to characteristic charge trains to aid the analyst in gel orientation. Molecular weights range from 17K to 80K, with pI values ranging from 4.5 to 8.7.

Info Pierce Biotechnology, Inc.Pierce Biotechnology, Inc.
Pierce Biotechnology, Inc.
3747 N. Meridian Rd.
P.O. Box 117
Rockford, IL 61105
Customer Service: 815-968-0747
Fax Number: 815-968-8148
Web Site: http://www.piercenet.com/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Modern Protein Chemistry: Practical Aspects from Pierce Biotechnology, Inc.
2. Protein-Protein Interactions, from Pierce Biotechnology, Inc.
3. Imject Freunds Complete Adjuvant (FCA) from Pierce Biotechnology, Inc.
4. Imject Freunds Incomplete Adjuvant (FIA) from Pierce Biotechnology, Inc.
5. Extracti-Gel D Detergent Removing Gel AffinityPak Columns from Pierce Biotechnology, Inc.
6. GUIDE TO PROTEIN PURIFICA from Pierce Biotechnology, Inc.
7. PROTEIN PROTOCOLS Book from Pierce Biotechnology, Inc.
8. Product Information Request - SuperSignal West Pico COMPLETE Biotinylated Protein Detection Kit from Pierce Biotechnology, Inc.
9. UltraLink Immobilized NeutrAvidin from Pierce Biotechnology, Inc.
10. DISCOVERLIGHT RABBIT ARRA from Pierce Biotechnology, Inc.
11. PATH Protein Microarray Kit from Pierce Biotechnology, Inc.
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
...
Assay Diluent 500 mls...
Mouse monoclonal [4C4] to Y14 ( Abpromise for all tested applications). entrezGeneID: 9939 SwissProtID: Q9Y5S9...
Biology Products:
(Date:6/14/2017)...  IBM (NYSE: IBM ) is introducing several innovative ... to developing collaboration between startups and global businesses, taking place ... the event, nine startups will showcase the solutions they have ... France is one ... a 30 percent increase in the number of startups created ...
(Date:4/24/2017)... April 24, 2017 Janice Kephart ... with  Identity Strategy Partners, LLP (IdSP) , today ... without President Trump,s March 6, 2017 Executive ... , refugee vetting can be instilled with greater confidence, ... now, all refugee applications are suspended by until ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by Solution ... Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to 2022", ... 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at a ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... (PRWEB) , ... October 12, ... ... today announces publication of a United States multicenter, prospective clinical study that ... disposable, point-of-care diagnostic test capable of identifying clinically significant acute bacterial and ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity of ... performing systematic gain-of-function studies. , This complement to loss-of-function studies, such as ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
Breaking Biology Technology: